Eden Research (EDEN)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.85p
   
  • Change Today:
    -0.15p
  • 52 Week High: 4.90p
  • 52 Week Low: 2.35p
  • Currency: UK Pounds
  • Shares Issued: 533.35m
  • Volume: 549,240
  • Market Cap: £15.20m
  • Beta: 0.04

Eden Research Overview

Eden Research is in the pharma and biotech sector and is currently trading at 2.85p per share. In the last year Eden Research's share price has ranged from 2.35p to 4.90p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -50.8% -36.0%
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 3.5 2.9
Pr/Book 1.3  
Latest F'cast
Revenue 34.8% 16.2%
PBT n/a n/a
EPS n/a -25.0%
DPS n/a n/a

Eden Research Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.37 (2.55) (0.66)p n/a n/a n/a n/a 0.0%
31-Dec-21 1.23 (3.40) (0.73)p n/a n/a n/a n/a 0.0%
31-Dec-22 1.83 (2.57) (0.59)p n/a n/a n/a n/a 0.0%
31-Dec-23 3.19 (6.92) (1.54)p n/a n/a n/a n/a 0.0%
31-Dec-24 4.30 (2.18) (0.36)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Eden Research Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 5.00 (1.80) (0.27)p n/a n/a -25% n/a 0.0%

Copyright © 2025 FactSet Research Systems Inc. All rights reserved.

Eden Research Company Announcements

Holding(s) in Company 06-May-2025 12:08 RNS
Preliminary results for the year ended 31 Dec 2024 06-May-2025 07:00 RNS
Thymol Supply Agreement For Bee Health 10-Apr-2025 07:00 RNS

Eden Research ShareCast News

Eden Research inks thymol supply deal with Veto-... 10-Apr-2025 ShareCast
Eden Research revenue rises, losses set to widen 13-Jan-2025 ShareCast
Eden Research gets approval for Novellus+ in Mex... 20-Dec-2024 ShareCast

Latest Eden Research Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Eden Research Market Data

Currency UK Pounds
Share Price 2.85p
Change Today -0.15p
% Change -5.00 %
52 Week High 4.90p
52 Week Low 2.35p
Volume 549,240
Shares Issued 533.35m
Market Cap £15.20m
Beta 0.04

Eden Research Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
3.53% below the market average3.53% below the market average3.53% below the market average3.53% below the market average3.53% below the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average
Price Trend
58.08% below the market average58.08% below the market average58.08% below the market average58.08% below the market average58.08% below the market average
12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average12.5% below the sector average
Income Not Available
Growth
53.05% above the market average53.05% above the market average53.05% above the market average53.05% above the market average53.05% above the market average
62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average62.50% above the sector average

Eden Research Dividends

No dividends found

Trades for 06-May-2025

Time Volume / Share Price
15:59 100,000 @ 2.83p
09:06 208,333 @ 2.88p
08:53 75,000 @ 2.80p
08:47 10 @ 2.88p
08:35 75,000 @ 2.90p

Eden Research Key Personnel

CFO Alexander John Abrey
CEO Sean M. Smith

Top of Page